Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1006336.RASfmnbjTaZpW68g3ox24DplP8wFZFEn9NoAwVwS-ff-Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1006336.RASfmnbjTaZpW68g3ox24DplP8wFZFEn9NoAwVwS-ff-Q130_assertion type Assertion NP1006336.RASfmnbjTaZpW68g3ox24DplP8wFZFEn9NoAwVwS-ff-Q130_head.
- NP1006336.RASfmnbjTaZpW68g3ox24DplP8wFZFEn9NoAwVwS-ff-Q130_assertion description "[The specific binding of insulin to either intact or Triton-solubilized Daudi cells (a Burkitt lymphoma cell line) was reduced by over 95% compared to that to control IM-9 lymphocytes due to a decrease in receptor number without a change in affinity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1006336.RASfmnbjTaZpW68g3ox24DplP8wFZFEn9NoAwVwS-ff-Q130_provenance.
- NP1006336.RASfmnbjTaZpW68g3ox24DplP8wFZFEn9NoAwVwS-ff-Q130_assertion evidence source_evidence_literature NP1006336.RASfmnbjTaZpW68g3ox24DplP8wFZFEn9NoAwVwS-ff-Q130_provenance.
- NP1006336.RASfmnbjTaZpW68g3ox24DplP8wFZFEn9NoAwVwS-ff-Q130_assertion SIO_000772 2664477 NP1006336.RASfmnbjTaZpW68g3ox24DplP8wFZFEn9NoAwVwS-ff-Q130_provenance.
- NP1006336.RASfmnbjTaZpW68g3ox24DplP8wFZFEn9NoAwVwS-ff-Q130_assertion wasDerivedFrom befree-20150227 NP1006336.RASfmnbjTaZpW68g3ox24DplP8wFZFEn9NoAwVwS-ff-Q130_provenance.
- NP1006336.RASfmnbjTaZpW68g3ox24DplP8wFZFEn9NoAwVwS-ff-Q130_assertion wasGeneratedBy ECO_0000203 NP1006336.RASfmnbjTaZpW68g3ox24DplP8wFZFEn9NoAwVwS-ff-Q130_provenance.